Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1.74% | 306.72 | 0.0% | $5256.57m | |
| BNTX | BioNTech SE | 3.17% | 344.06 | 0.0% | $1596.83m | |
| NVAX | Novavax, Inc. | -0.92% | 160.48 | 78.2% | $831.00m | |
| AMGN | Amgen, Inc. | 0.63% | 202.44 | 1.4% | $596.39m | |
| GILD | Gilead Sciences, Inc. | -0.16% | 69.56 | 1.0% | $505.86m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.18% | 635.16 | 2.7% | $472.48m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.31% | 203.81 | 1.9% | $464.56m | |
| LGVN | Longeveron Inc. | 11.78% | 20.12 | 0.0% | $429.77m | |
| ILMN | Illumina, Inc. | -2.85% | 347.28 | 3.3% | $324.28m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -4.21% | 4.10 | 0.7% | $286.61m | |
| BIIB | Biogen, Inc. | -2.01% | 223.92 | 1.8% | $276.52m | |
| INCY | Incyte Corp. | -1.28% | 65.78 | 2.4% | $150.25m | |
| SGEN | Seagen Inc. | -5.00% | 150.74 | 5.8% | $149.09m | |
| EXAS | EXACT Sciences Corp. | -4.94% | 76.59 | 18.0% | $140.15m | |
| OCGN | Ocugen, Inc. | -8.72% | 5.76 | 0.0% | $139.18m |
Company Profile
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Philadelphia, PA.